Bajaj Healthcare Limited (BAJAJHCARE) — Board Meeting

· NSE 🟡 Notable Neutral

The board approved the audited FY2025-26 standalone results showing a loss of ₹1941.28 lakhs, recommended a ₹1.50 per share (30% of face value) final dividend subject to shareholder approval, and reappointed auditors for FY2026-27. Total current liabilities rose to ₹31,956.24 lakhs from ₹27,226.63 lakhs, while cash and cash equivalents jumped to ₹3,723.54 lakhs from ₹260.38 lakhs. The unmodified auditor's report confirmed financial statement accuracy.

📄 View Original Announcement (PDF)

About Bajaj Healthcare Limited (BAJAJHCARE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹956.52 Cr P/E: 44.9

View full BAJAJHCARE stock details →

📡 Get AI alerts when BAJAJHCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BAJAJHCARE — Free

📊 More BAJAJHCARE filings

See all BAJAJHCARE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when BAJAJHCARE files new disclosures

Track BAJAJHCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BAJAJHCARE — Free

Free account · 2 AI queries/day